Skip to main content
. 2016 Oct 4;52(4):512–519. doi: 10.1007/s00535-016-1263-4

Fig. 2.

Fig. 2

a Waterfall plot of changes in tumor size by IRRC assessment. One patient was excluded from the plot due to lack of IRRC assessment of target legion at baseline. The patient marked with an asterisk showed a best overall response of SD. b Representative liver lesion of HCC at baseline on arterial phase CT. c Representative liver lesion on arterial phase CT after 1 year of lenvatinib treatment. CT computed tomography, HCC hepatocellular carcinoma, IRRC independent radiologic review committee, PD progressive disease, PR partial response, SD stable disease, NE not evaluable